Logo image of MBWS.PA

MARIE BRIZARD WINE & SPIRITS (MBWS.PA) Stock Fundamental Analysis

Europe - EPA:MBWS - FR0000060873 - Common Stock

2.92 EUR
-0.03 (-1.02%)
Last: 10/17/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, MBWS scores 3 out of 10 in our fundamental rating. MBWS was compared to 26 industry peers in the Beverages industry. While MBWS has a great health rating, there are worries on its profitability. MBWS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

MBWS had positive earnings in the past year.
In the past year MBWS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: MBWS reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: MBWS reported negative operating cash flow in multiple years.
MBWS.PA Yearly Net Income VS EBIT VS OCF VS FCFMBWS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of 3.46%, MBWS is in line with its industry, outperforming 48.28% of the companies in the same industry.
Looking at the Return On Equity, with a value of 4.52%, MBWS is doing worse than 75.86% of the companies in the same industry.
The Return On Invested Capital of MBWS (3.24%) is worse than 82.76% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MBWS is below the industry average of 7.35%.
The 3 year average ROIC (3.06%) for MBWS is below the current ROIC(3.24%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.46%
ROE 4.52%
ROIC 3.24%
ROA(3y)2.1%
ROA(5y)-1.19%
ROE(3y)2.78%
ROE(5y)-9.35%
ROIC(3y)3.06%
ROIC(5y)2.16%
MBWS.PA Yearly ROA, ROE, ROICMBWS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

MBWS has a Profit Margin of 5.12%. This is in the lower half of the industry: MBWS underperforms 72.41% of its industry peers.
In the last couple of years the Profit Margin of MBWS has grown nicely.
MBWS has a worse Operating Margin (4.72%) than 86.21% of its industry peers.
In the last couple of years the Operating Margin of MBWS has grown nicely.
MBWS has a worse Gross Margin (39.05%) than 79.31% of its industry peers.
In the last couple of years the Gross Margin of MBWS has remained more or less at the same level.
Industry RankSector Rank
OM 4.72%
PM (TTM) 5.12%
GM 39.05%
OM growth 3Y42.97%
OM growth 5YN/A
PM growth 3Y15.32%
PM growth 5YN/A
GM growth 3Y-1.72%
GM growth 5Y-1.12%
MBWS.PA Yearly Profit, Operating, Gross MarginsMBWS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MBWS is destroying value.
MBWS has about the same amout of shares outstanding than it did 1 year ago.
MBWS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, MBWS has a worse debt to assets ratio.
MBWS.PA Yearly Shares OutstandingMBWS.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
MBWS.PA Yearly Total Debt VS Total AssetsMBWS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

MBWS has an Altman-Z score of 4.19. This indicates that MBWS is financially healthy and has little risk of bankruptcy at the moment.
MBWS has a better Altman-Z score (4.19) than 86.21% of its industry peers.
MBWS has a debt to FCF ratio of 0.82. This is a very positive value and a sign of high solvency as it would only need 0.82 years to pay back of all of its debts.
MBWS's Debt to FCF ratio of 0.82 is amongst the best of the industry. MBWS outperforms 93.10% of its industry peers.
MBWS has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
MBWS has a better Debt to Equity ratio (0.03) than 93.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.82
Altman-Z 4.19
ROIC/WACC0.41
WACC7.98%
MBWS.PA Yearly LT Debt VS Equity VS FCFMBWS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

A Current Ratio of 2.71 indicates that MBWS has no problem at all paying its short term obligations.
MBWS has a better Current ratio (2.71) than 89.66% of its industry peers.
A Quick Ratio of 1.84 indicates that MBWS should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.84, MBWS belongs to the best of the industry, outperforming 96.55% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.71
Quick Ratio 1.84
MBWS.PA Yearly Current Assets VS Current LiabilitesMBWS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1

3. Growth

3.1 Past

MBWS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -43.44%.
MBWS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.49% yearly.
MBWS shows a decrease in Revenue. In the last year, the revenue decreased by -5.42%.
MBWS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.46% yearly.
EPS 1Y (TTM)-43.44%
EPS 3Y11.49%
EPS 5YN/A
EPS Q2Q%-59.86%
Revenue 1Y (TTM)-5.42%
Revenue growth 3Y4.17%
Revenue growth 5Y2.46%
Sales Q2Q%-8.76%

3.2 Future

Based on estimates for the next years, MBWS will show a decrease in Earnings Per Share. The EPS will decrease by 0.00% on average per year.
MBWS is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.36% yearly.
EPS Next Y-12.5%
EPS Next 2Y-6.46%
EPS Next 3Y0%
EPS Next 5YN/A
Revenue Next Year-5.32%
Revenue Next 2Y-1.61%
Revenue Next 3Y-0.36%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MBWS.PA Yearly Revenue VS EstimatesMBWS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
MBWS.PA Yearly EPS VS EstimatesMBWS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

0

4. Valuation

4.1 Price/Earnings Ratio

MBWS is valuated quite expensively with a Price/Earnings ratio of 58.40.
Compared to the rest of the industry, the Price/Earnings ratio of MBWS indicates a rather expensive valuation: MBWS more expensive than 82.76% of the companies listed in the same industry.
MBWS's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.42.
The Price/Forward Earnings ratio is 40.90, which means the current valuation is very expensive for MBWS.
82.76% of the companies in the same industry are cheaper than MBWS, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.94, MBWS is valued quite expensively.
Industry RankSector Rank
PE 58.4
Fwd PE 40.9
MBWS.PA Price Earnings VS Forward Price EarningsMBWS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

MBWS's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. MBWS is more expensive than 79.31% of the companies in the same industry.
MBWS's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. MBWS is more expensive than 72.41% of the companies in the same industry.
Industry RankSector Rank
P/FCF 35.22
EV/EBITDA 21.85
MBWS.PA Per share dataMBWS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.46%
EPS Next 3Y0%

0

5. Dividend

5.1 Amount

No dividends for MBWS!.
Industry RankSector Rank
Dividend Yield N/A

MARIE BRIZARD WINE & SPIRITS

EPA:MBWS (10/17/2025, 7:00:00 PM)

2.92

-0.03 (-1.02%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)09-25 2025-09-25
Earnings (Next)10-23 2025-10-23
Inst Owners5.34%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap327.01M
Analysts42.22
Price Target3.06 (4.79%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-9.09%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.29%
Valuation
Industry RankSector Rank
PE 58.4
Fwd PE 40.9
P/S 1.74
P/FCF 35.22
P/OCF 20.2
P/B 1.53
P/tB 2.63
EV/EBITDA 21.85
EPS(TTM)0.05
EY1.71%
EPS(NY)0.07
Fwd EY2.45%
FCF(TTM)0.08
FCFY2.84%
OCF(TTM)0.14
OCFY4.95%
SpS1.68
BVpS1.91
TBVpS1.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.46%
ROE 4.52%
ROCE 3.98%
ROIC 3.24%
ROICexc 3.78%
ROICexgc 6.95%
OM 4.72%
PM (TTM) 5.12%
GM 39.05%
FCFM 4.93%
ROA(3y)2.1%
ROA(5y)-1.19%
ROE(3y)2.78%
ROE(5y)-9.35%
ROIC(3y)3.06%
ROIC(5y)2.16%
ROICexc(3y)3.97%
ROICexc(5y)2.82%
ROICexgc(3y)8.7%
ROICexgc(5y)6.76%
ROCE(3y)3.76%
ROCE(5y)2.66%
ROICexcg growth 3Y30.28%
ROICexcg growth 5YN/A
ROICexc growth 3Y42.22%
ROICexc growth 5YN/A
OM growth 3Y42.97%
OM growth 5YN/A
PM growth 3Y15.32%
PM growth 5YN/A
GM growth 3Y-1.72%
GM growth 5Y-1.12%
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.82
Debt/EBITDA 0.5
Cap/Depr 144.28%
Cap/Sales 3.66%
Interest Coverage 250
Cash Conversion 118.37%
Profit Quality 96.28%
Current Ratio 2.71
Quick Ratio 1.84
Altman-Z 4.19
F-Score6
WACC7.98%
ROIC/WACC0.41
Cap/Depr(3y)199.06%
Cap/Depr(5y)172.98%
Cap/Sales(3y)2.69%
Cap/Sales(5y)2.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-43.44%
EPS 3Y11.49%
EPS 5YN/A
EPS Q2Q%-59.86%
EPS Next Y-12.5%
EPS Next 2Y-6.46%
EPS Next 3Y0%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.42%
Revenue growth 3Y4.17%
Revenue growth 5Y2.46%
Sales Q2Q%-8.76%
Revenue Next Year-5.32%
Revenue Next 2Y-1.61%
Revenue Next 3Y-0.36%
Revenue Next 5YN/A
EBIT growth 1Y10.35%
EBIT growth 3Y48.93%
EBIT growth 5YN/A
EBIT Next Year44.44%
EBIT Next 3Y18.56%
EBIT Next 5YN/A
FCF growth 1Y366.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y896.74%
OCF growth 3YN/A
OCF growth 5YN/A